Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clarke To Oversee Glaxo Consumer Division During Xenical Switch Bid

This article was originally published in The Pink Sheet Daily

Executive Summary

Proposed OTC weight loss drug would be “intended for adults,” firm says. Clarke eyes 2006 launch.

You may also be interested in...



Energizer Grows Personal Care With Acquisition Of Leading Sun-Care Brands

Energizer Holdings will gain Banana Boat and Hawaiian Tropic - the No. 2- and No. 4-selling sun- care brands, respectively - through its $1.9 billion purchase of Playtex Products, the companies announce July 12

Physicians Formula Continues To Solve Real, Perceived Problems Into 2008

Physicians Formula, which has found success distinguishing itself as a "problem/solution brand" since its inception, plans to remain competitive in 2008 and beyond with a three-pronged plan of attack, according to CEO Ingrid Jackel

Beauty TV Network To Grow Its Web Presence Through Partnership With Joost

Beauty TV - "the world's only 24/7 beauty television network" - will enjoy expanded distribution worldwide after partnering with Joost, touted as "a new way of watching TV on the Internet.

Topics

UsernamePublicRestriction

Register

PS062921

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel